3 Chronic GvHD also tends to start with a burning rash on the same parts of the body, although it can be more severe and ...

GvHD causes life-threatening immune system reactions in the skin, gastrointestinal (GI) tract and liver following a hematopoietic stem cell transplant, a treatment used for blood-based cancers.

Skin is the most commonly affected organ in graft-versus-host disease (GVHD). To explore the role of Langerhans cells in GVHD, the principal dendritic cells of the skin, we studied the fate of ...

Belumosudil has both breakthrough and orphan drug designations for chronic GVHD, and is also being studied in a mid-stage trial in diffuse cutaneous systemic sclerosis, a subtype of rare disease ...

Ten patients had gastrointestinal GVHD, four had liver GVHD, and five had skin GVHD. The median number of doses of infliximab 10 mg/kg was four (range, one to eight). Although 10 (63%) patients ...

The FDA has approved Incyte's axatilimab as a treatment for chronic graft-versus-host disease (GvHD), making it a companion to the company's Jakafi for the disorder. The US regulator has cleared ...

Considering taking supplements to treat graft versus host disease gvhd? Below is a list of common natural remedies used to treat or reduce the symptoms of graft versus host disease gvhd.